Source: Journal of Applied Physiology. Unidade: FMRP
Subjects: METABOLISMO DE PROTEÍNA, MÚSCULO ESQUELÉTICO, RATOS, DIABETES MELLITUS
ABNT
ARCARO, Carlos Alberto et al. Involvement of cAMP/EPAC/Akt signaling in the antiproteolytic effects of pentoxifylline on skeletal muscles of diabetic rats. Journal of Applied Physiology, v. 124, n. 3, p. 704-716, 2018Tradução . . Disponível em: https://doi.org/10.1152/japplphysiol.00499.2017. Acesso em: 10 set. 2024.APA
Arcaro, C. A., Assis, R. P., Zanon, N. M., Paula-Gomes, S., Navegantes, L. C. C., Kettelhut, I. C., et al. (2018). Involvement of cAMP/EPAC/Akt signaling in the antiproteolytic effects of pentoxifylline on skeletal muscles of diabetic rats. Journal of Applied Physiology, 124( 3), 704-716. doi:10.1152/japplphysiol.00499.2017NLM
Arcaro CA, Assis RP, Zanon NM, Paula-Gomes S, Navegantes LCC, Kettelhut IC, Brunetti IL, Baviera AM. Involvement of cAMP/EPAC/Akt signaling in the antiproteolytic effects of pentoxifylline on skeletal muscles of diabetic rats [Internet]. Journal of Applied Physiology. 2018 ; 124( 3): 704-716.[citado 2024 set. 10 ] Available from: https://doi.org/10.1152/japplphysiol.00499.2017Vancouver
Arcaro CA, Assis RP, Zanon NM, Paula-Gomes S, Navegantes LCC, Kettelhut IC, Brunetti IL, Baviera AM. Involvement of cAMP/EPAC/Akt signaling in the antiproteolytic effects of pentoxifylline on skeletal muscles of diabetic rats [Internet]. Journal of Applied Physiology. 2018 ; 124( 3): 704-716.[citado 2024 set. 10 ] Available from: https://doi.org/10.1152/japplphysiol.00499.2017